Novartis' Piqray/Vijoice (alpelisib) is the only PIK3CA inhibitor to have reached the market for breast cancer, having been ...

The French drugmaker laid out plans to separate its consumer division--home to brands such as Allegra, Dulcolax and IcyHot--from its innovative medicines and vaccines businesses a year ago. With its ...

The treatment of metabolic dysfunction-associated steatohepatitis (MASH) has proven challenging, with many compounds failing during development for various reasons. However, with the recent ...

Gritstone Bio announced it is “taking action” to “preserve value and strengthen capital structure” on Thursday.

Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...

Itovebi — also known as inavolisib — is designed to be given with drugs from Pfizer Inc. and AstraZeneca plc to treat adults ...

There was some intriguing news from a Pfizer (NYSE: PFE) shareholder on Thursday that was not taken well by the market.

As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard ...

Dr. Tam Ky Nguyen, an internal medicine physician, faces possible discipline from the California Medical Board for alleged ...

Hedge fund Starboard Value's activist campaign targeting Pfizer (PFE) divides Wall Street, with analysts questioning the ...

Starboard said a former CEO and CFO had assisted in its activist campaign but then were pressured to express support for the ...

Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current CEO ...